Postoperative Analgesic Effects of Dexmedetomidine for Transversus Abdominis Plane Block
Information source: TC Erciyes University
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Pain
Intervention: Bupivacaine (Drug); Dexmedetomidine (Drug); serum physiologic (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: TC Erciyes University Official(s) and/or principal investigator(s):
Recep Aksu, assoc. prof., Study Director, Affiliation: Erciyes universty medicine faculty
Gülçin Patmano, resident, Principal Investigator, Affiliation: Erciyes universty medicine faculty
Overall contact:
Recep Aksu, assoc prof., Phone: +903522076666, Ext: 24035, Email: raksu@erciyes.edu.tr
Summary
the aim of this study is evaluate postoperative analgesic effects of dexmedetomidine added
to bupivacaine on TAP block in patients undergoing lower abdominal surgery.
Clinical Details
Official title: Postoperative Analgesic Effects of Dexmedetomidine Added to Bupivacaine for Transversus Abdominis Plane Block for Lower Abdominal Surgery
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: opioid consumption
Secondary outcome: visual analog scale
Detailed description:
TAP block is being used a method of multimodal balanced analgesia reduces postoperative
pain, opioid requirement after surgery and adverse effect of opioid such as sedation, nausea
vomiting and ileus. Dexmedetomidine ,an alfa-2 adrenoreceptor agonist, is being used and
adjuvant capable of prolonging duration of sensory and motor block on nerve blocks.
Eligibility
Minimum age: 18 Years.
Maximum age: 65 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- ASA 1-2
- 18-65 aged
- patient undergoing lower abdominal surgery
Exclusion Criteria:
- chronic opioid consumption
- bupivacaine and dexmedetomidine allergies
- coagulopathy
- infection at the needle insertion side
- chronic liver and kidney disease
Locations and Contacts
Recep Aksu, assoc prof., Phone: +903522076666, Ext: 24035, Email: raksu@erciyes.edu.tr
Erciyes universty, Kayseri, Melikgazi 38039, Turkey; Recruiting
Recep Aksu, assoc.prof., Phone: +903522076666, Ext: 24035, Email: raksu@erciyes.edu.tr
Gülçin Patmano, resident, Phone: +905554012878, Email: gpatmano@erciyes.edu.tr
Additional Information
Starting date: February 2014
Last updated: November 7, 2014
|
